Skip to main content
. 2020 Jun 25;10:936. doi: 10.3389/fonc.2020.00936

Table 1.

Patient characteristics.

High dose Moderate dose
P-Value
Age <70 51% 31%
≥70 49% 69% p = 0.0015
Gleason Score
6 38% 50%
7 62% 50% 0.0441
Initial PSA
<10 83% 80% p = 0.6075
10.0–20 17% 20%